Infinium Global Research has added a new report on Non-Small Cell Lung Cancer Therapeutics Market. The report presents analysis of global as well as regional markets of non-small cell lung cancer therapeutics market over the period of 2016 to 2024.
The non-small cell lung cancer is a type of lung cancer arising in the epithelial tissue, and it is different than the small cell lung cancer. This non-small cell lung cancer is the most common lung cancer among all types of lung cancers. Most often, treatment for NSCLC uses a combination of 2 chemo drugs. Studies have shown that adding a third chemo drug doesn’t add much benefit and is likely to cause more side effects.
The report defines the market of non-small cell lung cancer on the basis of the treatment types including Early/non-metastatic NSCLC, Advanced/metastatic NSCLC, EGFR mutations, ALK gene rearrangements, and other treatment options.
The air pollution is increasing rapidly across the all over the globe. According to the world health organization the outdoor air pollution is the main cause of lung cancer. Rising smoking habit among the population and the increasing air population drives the market growth of non-small cell lung cancer therapeutics market. The American Cancer Society’s, recorded an average of about 2,34,030 new cases of lung cancer and about 1,54,050 deaths from lung cancer up to 2018. Moreover, the ongoing R&D on non-small cell lung cancer therapies, growing focus on healthcare sectors, and introduction of new drugs are projected to create more opportunities in this market in upcoming years.
Geographically, North America dominates the market of non-small cell lung cancer therapeutics market. The government of North America supports the research activity that results in the up gradation of existing drugs and development of new advanced and effective drugs are increasing. The presence of major players and increased advancements in this sectors are expected to boost the market of non-small cell lung cancer therapeutics in this region between the period of 2018 to 2024
Moreover, the growth matrix presented by Infinium Global Research identifies the key investment markets in the near future, this will not only help the companies to understand the competitive position in the global non-small cell lung cancer therapeutics market but also make strategic decisions to capture the most lucrative markets in the near future. The market size is presented in terms of value for the historic year 2016 and estimated for forecast period of 2018-2024.
.
Get 15% discount for early purchase of global non-small cell lung cancer therapeutics market report by clicking the following link, Use code IGRD15 to request the discount in the given form
https://www.infiniumglobalresearch.com/reports/request-discount/1332
The recent report identified that dominated the global non-small cell lung cancer therapeutics market over the last couple of years, while emerging markets of Asia-Pacific and Latin America are anticipated to contribute significantly to the growth in the non-small cell lung cancer therapeutics market worldwide.
The report segments the global non-small cell lung cancer therapeutics market on the basis of Drug class.
Global Non-small Cell Lung Cancer Therapeutics Market by Drug Class
· Angiogenesis Inhibitor
· Kinase Inhibitor
· Epidermal Growth Factor Receptor Blocker
· Folate Antimetabolites
· PD-1/ PD-L1 Inhibitor
· Microtubule Stabilizer
Companies Profiled in the Report
· Celgene Corporation
· Bristol-Myers Squibb
· Novartis AG
· Eli Lilly
· Pfizer
· straZeneca plc
· Merck KGaA,
· F. Hoffmann-La Roche Ltd
· AstraZeneca
· Orion Corporation
About Infinium Global Research
Infinium Global Research is a business intelligence company that provides its clients with market information services, solutions, and reports. The intelligence reports include qualitative as well as quantitative information, which are blended using forecasting models in order to project future market demand. Our panels of Subject Matter Experts (SMEs), Analysts, and Consultants use numerous data gathering tools in order to provide you with detailed information on the market as well as a preview of its projected growth. Our repository includes the largest and most credible databases, through which we determine various qualitative and quantitative parameters of the market to provide you with an in-depth business intelligence report.
Infinium Global Research reports and consulting services cover numerous sectors, which include healthcare, chemicals, materials, energy, packaged goods, food and beverages, technology, and communications. These reports provide readers with market insights and detailed analysis of market segments to possible micro levels. Our reports, with stratified research methodology and wider scope of analysis, provide clients with crucial insights and information to meet their every requirement.
